Antal patienter (%) med respons samt 95% konfidensintervaller (CI) er opgivet. ‡ Ved den prognostiske analyse blev virologisk svigt analyseret som "carry forward" for procent med henholdsvis < 400 og ≤ 50 kopier/ ml.
Percent of patients with response and associated 95% confidence interval (CI) are reported. ‡ For analysis by prognostic factors, virologic failures were carried forward for percent < 400 and 50 copies/ ml.